ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Ultrasound Therapy for Fibromyalgia and Lyme Disease

Curcumin: The All In One Solution, Part 2

What Are the Benefits of Vitamin K2?

Vitamin D deficiency + high fat diet = metabolic syndrome

Why You Should Take Your Apple Cider Vinegar at Night

Use Burdock Oil to Promote Healthy Hair Growth

Meet Your Weight Loss Goals

AMA journal associates iron deficiency with hearing loss

People with forms of early-onset Parkinson's disease may benefit from boosting niacin in diet, resea...

Lutein linked to preservation of crystallized intelligence

 
Print Page
Email Article

Arthritis Drugs may Improve Heart Health

  [ 52 votes ]   [ Discuss This Article ]
www.ProHealth.com • January 24, 2003


Anti-inflammatory drugs used to treat arthritis may also benefit people with heart disease by improving blood vessel flexibility and reducing inflammation, according to a small study published in the rapid track report from Circulation: Journal of the American Heart Association.

"Increasing evidence indicates that atherosclerosis is an inflammatory disease," says senior author Frank Ruschitzka, M.D., of the department of cardiology at University Hospital in Zürich, Switzerland. "Thus, anti-inflammatory agents used to treat arthritis, such as COX-2 inhibitors, may not only reduce inflammation in the joints, but could possibly have that same anti-inflammatory benefit in the vessel wall. This study is the first to show that relationship."

COX-2 inhibitors such as celecoxib (trade name Celebrex) are second-generation anti-inflammatory drugs – known as nonsteroidal anti-inflammatory drugs (NSAIDs) – used for arthritis and other inflammatory conditions. These newer painkillers are associated with a lower incidence of stomach irritation than other NSAIDs, such as aspirin and ibuprofen.

Swiss researchers studied 14 male patients, aged 46 to 77, with severe heart disease. They had standard cardiovascular therapy that includes blood-thinning aspirin and lipid-lowering statin drugs. The patients received 200 milligrams of celecoxib or placebo for two weeks. Afterwards, the groups switched treatments.

Researchers assessed endothelial function, C-reactive protein (CRP), oxidized low-density lipoprotein (ox-LDL), and prostaglandins following treatment.

Endothelial function is a measurement of how well the inner lining of the blood vessels (the endothelium) controls expansion and contraction of the vessel. If the endothelium is coated with fatty deposits, it is less able to help the blood vessel expand. Other parts of the blood vessel, such as the muscular wall of the vessel itself, are also involved in expanding and contracting, but different mechanisms control this action so it is independent of endothelial function.

A process called flow-mediated dilation of the brachial artery (in the arm) was used to measure endothelium expansion and blood flow. Celecoxib improved endothelium-dependent vasodilation by 3.3 percent, while those on placebo improved by 2 percent. As a control, the researchers also measured endothelium-independent vasodilation, induced by the drug nitroglycerin.

This measure was about the same between the placebo and treatment groups. CRP is a protein the body releases in reaction to inflammation. Elevated levels are associated with increased risk for cardiovascular disease. CRP levels were 1.3 mg/L after celecoxib, compared with 1.8 mg/L after placebo.

Ox-LDL is a form of LDL (the so-called "bad" cholesterol) that has combined with oxygen and is considered more dangerous than LDL because it promotes clogging of blood vessels. Levels of ox-LDL were 43.6 U/L after celecoxib compared with 47.6 U/L after placebo.

Prostaglandins, which contribute to the proper functioning of the stomach, were the same between the two groups.

"This is the first study to demonstrate that a selective COX-2 inhibitor on top of standard therapy improves endothelial function and reduces markers of inflammation and oxidative stress in patients with coronary artery disease," write the researchers.

Another important finding is that celecoxib improves nitric oxide (NO)–mediated endothelial function. NO is important in maintaining blood vessel tone. Decreased nitric oxide production may indicate heart disease progression.

"The findings of the present study show that celecoxib improves NO-mediated endothelial function, which in turn may help improve blood vessel function."

The researchers further explain the significance of reduced ox-LDL as a major cardiovascular benefit of celecoxib therapy by noting that there is an increasing body of evidence that oxidative stress, such as high levels of ox-LDL, is a major culprit of endothelial dysfunction. They also add "there is evidence that COX-2 may be a source of oxygen radicals itself, and therefore inhibition of the enzyme activity may reduce oxidative stress.

"The results of our study suggest that COX-2 inhibition with celecoxib has potential as an add-on therapy to standard treatment," such as statins and ACE inhibitors, for patients with heart disease, state the authors.

"However, the definitive answer as to the net effect of selective COX-2 inhibition on cardiovascular events can only be provided by well-designed large-scale clinical trials," says Ruschitzka.



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Ultra ATP+, Double Strength Optimized Curcumin Longvida®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health
Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones
Fighting Fatigue with Ground-breaking French Oak Wood Extract Fighting Fatigue with Ground-breaking French Oak Wood Extract
IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map